DXCM Dexcom Inc

Q: Which ETFs hold DXCM?

Dexcom Inc (DXCM) is held by 4 funds tracked by ETFpeek as of 31 Aug 2026: VUG (0.12%), USG (0.12%), VOO (0.05%), USF (0.05%).

Which ETFs hold DXCM? Dexcom Inc is held by 4 funds tracked by ETFpeek.

Held by 4 funds todayData as of 31 Aug 2026

HealthcareMedical Devices

$84.41

+29.6% 1y

$54.1152-week range$92.59

Market cap

$32.2B

P/E

33.5

3-month

+12.6%

CEO

Mr. Jacob Steven Leach

Revenue · last 4 qtrs (+13.1% YoY)

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

Currently Held By

Smart US Large Growth ETF

via VUG

Weight in fund0.12%

Shares held—

Market value$740K NZD

Shares held10,252,607

via VOO

Market value$666K NZD

View fund →

Not held by the selected provider.

Insider Activity i

last 90 days

Net flow (90d):−$5.8M (1 without value)·0 BUY / 14 SELL·score ≥ 40

Date	Person	Action	Plan	Shares	Value	Score i
20 Aug 2026	Kevin R Sayer Executive Chairman of the Board	SELL	Unknown	26,659 2 tranches	$2.4M	90
20 Jul 2026	Kevin R Sayer Executive Chairman of the Board	SELL	Unknown	26,756	$2.0M	90

Net flow (90d):−$5.8M (1 without value)·0 BUY / 14 SELL·showing all trades

Date	Person	Action	Plan	Shares	Value	Score i
27 Aug 2026	Sadie Stern Executive VP, Chief People & Culture Officer	SELL	Unknown	2,565	$227K	30
22 Aug 2026	Jacob Steven Leach President, CEO & Director	SELL	Vested (RSU)	1,451	$134K	30
22 Aug 2026	Jereme M Sylvain Director / Other	SELL	Vested (RSU)	1,451	$134K	30
22 Aug 2026	Michael Jon Brown Executive VP, Chief Legal & Compliance Officer	SELL	Vested (RSU)	1,451	$134K	30
22 Aug 2026	Sadie Stern Executive VP, Chief People & Culture Officer	SELL	Vested (RSU)	1,451	$134K	30
20 Aug 2026	Kevin R Sayer Executive Chairman of the Board	SELL	Unknown	26,756 3 tranches	$2.4M	90
12 Aug 2026	Bridgette P Heller Director / Other	SELL	Unknown	1,012	$89K	30
12 Aug 2026	Nicholas Augustinos Director / Other	SELL	Unknown	1,075	—	30
3 Aug 2026	Mark G Foletta Director / Other	SELL	Unknown	2,000	$171K	30
31 Jul 2026	Mark G Foletta Director / Other	SELL	Unknown	2,000	$160K	30
20 Jul 2026	Kevin R Sayer Executive Chairman of the Board	SELL	Unknown	26,756	$2.0M	90
15 Jul 2026	Michael Jon Brown Executive VP, Chief Legal & Compliance Officer	SELL	Unknown	1,700	$127K	30

Data: Finnhub (SEC Form 4 filings) · Score: ETFpeek heuristic

Trade History

0 trades

Date	Fund	Direction	Shares Changed	% Δ ETF i	% Δ Position i
No trades recorded yet.
No trade history for SmartShares funds — their underlying ETFs are passive index trackers, so day-to-day rebalancing is minimal.

DXCM Dexcom Inc

Currently Held By

Insider Activity i

Trade History

More stocks in these funds